Hostname: page-component-78c5997874-g7gxr Total loading time: 0 Render date: 2024-11-16T09:52:50.415Z Has data issue: false hasContentIssue false
  • English
  • Français

Bipolar Disorder and ADHD: Clinical Concerns

Published online by Cambridge University Press:  07 November 2014

Roger McIntyre
Get access Rights & Permissions [Opens in a new window]

Extract

During the past decade, a similar composite has emerged for both bipolar disorder and adult attention-deficit/hyperactive disorder (ADHD). First, both conditions have a relatively high prevalence, a low case detection, a protracted illness course, a high rate of comorbidity, multifactorial ideology, substantial heritable liability, and tremendous burden of illness in economic cost as well as interpersonal and vocational maladjustments. What has also been interesting along with these reports is that there has been emerging scientific studies implicating common brain regions and neural circuits subserving essential features of both conditions.

Type
Expert Panel Supplement
Information
CNS Spectrums , Volume 14 , Issue S6: Differential Diagnosis of Adult Attention deficit/Hyperactivity Disorder: Treatment Options and Comorbidity Considerations , July 2009 , pp. 8 - 9
Copyright
Copyright © Cambridge University Press 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Faraone, SV. ADHD in adults-a familiar disease with unfamiliar challenges. CNS Spectr. 2007;12(suppl 23):14–17.CrossRefGoogle ScholarPubMed
2.Biederman, J. Attention-deficit/hyperactivity disorder a selective overview. Biol Psychiatry. 2005;57(11):1215–1220.Google Scholar
3.McIntyre, RS, Konarski, JZ. Bipolar disorder: a national health concern. CNS Spectr. 2004;9(11 suppl 12):6–15.Google Scholar
4.Kessler, RC, Adler, L, Barkley, R, et al.The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry. 2006;163(4):716–723.Google Scholar
5.Spencer, TJ, Biederman, J, Wilens, TE, Faraone, SV. Overview and neurobiology of attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2002;63(suppl 12):3–9.Google Scholar
6.Konarski, JZ, McIntyre, RS, Kennedy, SH, Rafi-Tari, S, Soczynska, JK, Ketter, TA. Volumetric neuroimaging investigations in mood disorders: bipolar disorder versus major depressive disorder. Bipolar Disord. 2008;10(1):1–37.Google Scholar
7.Seidman, LJ, Valera, EM, Makris, N. Structural brain imaging of attention-deficit/hyperactivity disorder. Biol Psychiatry. 2005;57(11):1263–1272.Google Scholar
8.Nierenberg, AA, Miyahara, S, Spencer, T. et al, and the STEP-BD Investigators. Clinical and diagnostic implications of lifetime attention-deficit/hyperactivity disorder comorbidity in adults with bipolar disorder: data from the first 1000 STEP-BD participants. Biol Psychiatry. 2005;57(11):1467–1473.Google Scholar
9.Hirschfeld, RM. Introduction: an overview of the issues surrounding the recognition and management of bipolar disorder and comorbid anxiety. J Clin Psychiatry. 2006;67(suppl 1):3–4.Google Scholar
10.Geller, B, Tillman, R, Bolhofner, K, Zimerman, B. Child bipolar I disorder: prospective continuity with adult bipolar I disorder; characteristics of second and third episodes; predictors of 8-year outcome. Arch Gen Psychiatry. 2008;65(10):1125–1133.Google Scholar
11.McIntyre, RS, Konarski, JZ. Bipolar disorder: a national health concern. CNS Spectr. 2004;9(11 suppl 12):6–15.CrossRefGoogle ScholarPubMed
12.Suppes, T, Dennehy, EB, Swann, AC, et al, and the Texas Consensus Conference Panel on Medication Treatment of Bipolar Disorder Report of the Texas Consensus Conference Panel on medication treatment of bipolar disorder 2000. J Clin Psychiatry. 2002;63(4):288–299.Google Scholar
13.Yatham, IN, Kennedy, SH, Schaffer, A, et al.Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disord. 2009;11(3):225–255.CrossRefGoogle Scholar
14.Wingo, AP, Ghaemi, SN. Frequency of stimulant treatment and of stimulant-associated mania/hypomania in bipolar disorder patients. Psychopharmacol Bull. 2008;41(4):37–47.Google Scholar
15.Scheffer, RE, Kowatch, RA, Carmody, T, Rush, AJ. Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium. Am J Psychiatry. 2005;162(1):58–64.CrossRefGoogle ScholarPubMed
16.Henderson, TA, Hartman, K. Aggression, mania, and hypomania induction associated with atomoxetine. Pediatrics. 2004;114(3):895–896.Google Scholar